Katherine Poehling to Pneumococcal Infections
This is a "connection" page, showing publications Katherine Poehling has written about Pneumococcal Infections.
Connection Strength
2.044
-
Poehling KA, Light LS, Rhodes M, Snively BM, Halasa NB, Mitchel E, Schaffner W, Craig AS, Griffin MR. Sickle cell trait, hemoglobin C trait, and invasive pneumococcal disease. Epidemiology. 2010 May; 21(3):340-6.
Score: 0.354
-
Peters TR, Poehling KA. Invasive pneumococcal disease: the target is moving. JAMA. 2007 Apr 25; 297(16):1825-6.
Score: 0.287
-
Poehling KA, Szilagyi PG, Grijalva CG, Martin SW, LaFleur B, Mitchel E, Barth RD, Nuorti JP, Griffin MR. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics. 2007 Apr; 119(4):707-15.
Score: 0.286
-
Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, Lexau CA, Thomas AR, Harrison LH, Reingold AL, Hadler JL, Farley MM, Anderson BJ, Schaffner W. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA. 2006 Apr 12; 295(14):1668-74.
Score: 0.267
-
Poehling KA, Lafleur BJ, Szilagyi PG, Edwards KM, Mitchel E, Barth R, Schwartz B, Griffin MR. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics. 2004 Sep; 114(3):755-61.
Score: 0.239
-
Poehling KA, Szilagyi PG, Edwards K, Mitchel E, Barth R, Hughes H, Lafleur B, Schaffer SJ, Schwartz B, Griffin MR. Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation. Pediatr Infect Dis J. 2003 May; 22(5):413-8.
Score: 0.218
-
Stancil JM, Peters TR, Givner LB, Poehling KA. Potential impact of accelerating the primary dose of pneumococcal conjugate vaccine in infants. Arch Pediatr Adolesc Med. 2009 May; 163(5):422-5.
Score: 0.082
-
Grijalva CG, Poehling KA, Nuorti JP, Zhu Y, Martin SW, Edwards KM, Griffin MR. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006 Sep; 118(3):865-73.
Score: 0.069
-
Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, Schaffner W, Craig AS, Griffin MR. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005 May 19; 352(20):2082-90.
Score: 0.063
-
Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM, Schaffner W, Craig AS, Griffin MR. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med. 2005 Mar; 118(3):285-91.
Score: 0.062
-
Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2004 Sep 01; 39(5):641-8.
Score: 0.060
-
Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J. 2004 Aug; 23(8):726-31.
Score: 0.059